Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Elliot Dasenbrook"'
Publikováno v:
Journal of Clinical & Translational Endocrinology, Vol 23, Iss , Pp 100253- (2021)
Coronavirus disease 2019 (COVID-19) was declared a pandemic on March 11, 2020. In efforts to reduce the risk of transmission, telehealth visits for routine care has significantly increased in the United States. Cystic fibrosis patients have been cate
Externí odkaz:
https://doaj.org/article/36eeee0138ad4f8b8f128178657ef888
Autor:
Erica A. Roesch, Tracey L. Bonfield, Hillard M. Lazarus, Jane Reese, Kathleen Hilliard, Jay Hilliard, Umer Khan, Sonya Heltshe, Adam Gluvna, Elliot Dasenbrook, Arnold I. Caplan, James F. Chmiel
Publikováno v:
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
Mesenchymal stem cells are of particular interest in cystic fibrosis (CF) as a potential therapeutic. Data from pre-clinical studies suggest that allogeneic bone marrow-derived human mesenchymal stem cells (hMSCs) may provide a new therapeutic treatm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::629a36e2c6ab964c1a7504907a1c82dc
https://pubmed.ncbi.nlm.nih.gov/36549988
https://pubmed.ncbi.nlm.nih.gov/36549988
Autor:
Melissa Skeans, Albert Faro, Maryam Valapour, Aliza K. Fink, Carli J. Lehr, Gabriela Fernandez, Elliot Dasenbrook
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 200:1013-1021
Rationale: Clinical variables associated with shortened survival in patients with advanced-stage cystic fibrosis (CF) are not included in the lung allocation score (LAS).Objectives: To identify variables associated with wait-list and post-transplant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::45005f0f02b9f68e305627168d032f5c
https://doi.org/10.1164/rccm.201902-0252oc
https://doi.org/10.1164/rccm.201902-0252oc
Autor:
Elliot Dasenbrook
Publikováno v:
Cleveland Clinic Journal of Medicine.
No specific data exists regarding management of patients with cystic fibrosis (CF) who are infected with COVID-19. Based on expert opinion, strategies for outpatient management include use of elexacaftor-tezacaftor-ivacaftor to reduce pulmonary exace
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0509e12d32e63d882bf1bbe84eac5ea0
https://doi.org/10.3949/ccjm.87a.ccc005
https://doi.org/10.3949/ccjm.87a.ccc005
Publikováno v:
Journal of Clinical & Translational Endocrinology, Vol 23, Iss, Pp 100253-(2021)
Journal of Clinical & Translational Endocrinology
Journal of Clinical & Translational Endocrinology
Coronavirus disease 2019 (COVID-19) was declared a pandemic on March 11, 2020. In efforts to reduce the risk of transmission, telehealth visits for routine care has significantly increased in the United States. Cystic fibrosis patients have been cate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e62a332b344d5c523239431541a5c63
https://doi.org/10.1016/j.jcte.2021.100253
https://doi.org/10.1016/j.jcte.2021.100253
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.